Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studies
What is this summary about? Generalized myasthenia gravis (often shortened to gMG) is a rare health condition that causes muscular weakness. This summary gives an overview of three published articles that report the results of research studies of a medicine called ravulizumab, a treatment approv...
Saved in:
| Main Authors: | Florencia Aguirre, Renata Andrade |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Becaris Publishing Limited
2024-10-01
|
| Series: | Journal of Comparative Effectiveness Research |
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term effectiveness and safety of ravulizumab in paroxysmal nocturnal hemoglobinuria: a plain language summary
by: Celso Arrais, et al.
Published: (2025-07-01) -
The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis
by: Armando Martinez Salazar, et al.
Published: (2025-05-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01) -
Eculizumab or ravulizumab treatment effect in people with neuromyelitis optica spectrum disorder: a plain language summary of three studies
by: Alfredo Damasceno, et al.
Published: (2025-02-01) -
Isolated Bilateral Triceps Weakness in Myasthenia Gravis
by: Betül Özenç, et al.
Published: (2024-04-01)